杰德生物科技

最新新闻

• H.C. Wainwright Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $55
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• 评级变动
  Jefferies Maintains Jade Biosciences(JBIO.US) With Buy Rating, Raises Target Price to $48
  \u5e02\u573a\u8d44\u8baf · 2026/8/12
• 评级变动
  A Quick Look at Today's Ratings for Jade Biosciences(JBIO.US), With a Forecast Between $40 to $74
  \u5e02\u573a\u8d44\u8baf · 2026/6/2
• 评级变动
  UBS Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/6/15
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Sagimet Biosciences, Inc. Class A (SGMT) and Jade Biosciences (JBIO)
  TipRanks · 2026/10/1
• William Blair Maintains Jade Biosciences(JBIO.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• 评级变动
  Clear Street Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $48
  \u5e02\u573a\u8d44\u8baf · 2026/9/4
• 评级变动
  UBS Initiates Jade Biosciences(JBIO.US) With Buy Rating, Announces Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/6/15
• 评级变动
  Wedbush Maintains Jade Biosciences(JBIO.US) With Buy Rating, Raises Target Price to $45
  \u5e02\u573a\u8d44\u8baf · 2026/6/2
• 评级变动
  Stifel Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $40
  \u5e02\u573a\u8d44\u8baf · 2026/8/14
• 评级变动
  Guggenheim Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $32
  \u5e02\u573a\u8d44\u8baf · 2026/5/27
• LifeSci Capital Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $42
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• 评级变动
  Guggenheim Maintains Jade Biosciences(JBIO.US) With Buy Rating, Raises Target Price to $32
  \u5e02\u573a\u8d44\u8baf · 2026/5/11
• 评级变动
  A Quick Look at Today's Ratings for Jade Biosciences(JBIO.US), With a Forecast Between $42 to $77
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• Guggenheim Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $47
  \u5e02\u573a\u8d44\u8baf · 2026/10/2
• 评级变动
  Wedbush Maintains Jade Biosciences(JBIO.US) With Buy Rating, Announces Target Price $47
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• 评级变动
  Clear Street Maintains Jade Biosciences(JBIO.US) With Buy Rating, Raises Target Price to $48
  \u5e02\u573a\u8d44\u8baf · 2026/9/4
• Wedbush Initiates Jade Biosciences(JBIO.US) With Buy Rating, Announces Target Price $47
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• 评级变动
  BTIG Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $39
  \u5e02\u573a\u8d44\u8baf · 2026/5/27
• 评级变动
  H.C. Wainwright Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/5/12

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。